drugset / Trial / NCT00199823

Autologous Stem Cell Transplantation in Acute Myocardial Infarction

NCT00199823 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Objectives Intracoronary transplantation of different cell populations have been used in acute myocardial infarction (AMI) with promising results. The primary objective of the ASTAMI study is to test whether intracoronary transplantation of autologous mononuclear bone marrow cells (mBMC) improve left ventricular ejection fraction (LVEF) after anterior wall AMI. Design The ASTAMI study is a randomized, controlled, prospective study. One hundred patients with acute anterior wall ST-elevation myocardial infarction (STEMI) treated with acute PCI are randomized in a 1:1 way to either intracoronary transplantation of autologous mBMC 5-8 days after PCI or to control. Left ventricular function, exercise capacity, biochemical status, functional class, quality of life and complications are validated at baseline and during a 12-month follow up.

Timeline

Start
2003-09
Primary completion
—
Completion
2006-05

Outcome

Missed primary endpoint

paper The effect of BMC treatment on the change in LVEF was an increase of 0.6 percentage point (95% confidence interval [CI], -3.4 to 4.6; P=0.77) PMID 16990383 ↗

paper With the methods used, we found no effects of intracoronary injection of autologous mononuclear BMC on global left ventricular function. PMID 16990383 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous mononuclear bone marrow cells Cell therapy — Other